Fact 6: Emerging artemisinin resistance is a major concern
Parasite resistance to artemisinin, the core compound in WHO-recommended combination treatments for uncomplicated malaria, has been detected in 5 countries of south east Asia: Cambodia, Laos, Myanmar, Thailand and Viet Nam. However, artemisinin-based combination therapies remain effective in almost all settings, as long as the partner drug in the combination is locally effective.
事实6: 新出现的青蒿素耐药性是关注的重大问题
青蒿素是世卫组织推荐的针对无并发症疟疾的联合疗法中的核心成分,已经在5个东南亚国家发现了对其产生耐药性的寄生虫:柬埔寨、老挝、缅甸、泰国和越南。然而,只要联合疗法中的搭配药物在当地有效,以青蒿素为基础的联合疗法在绝大多数情况下依旧具有疗效。